Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James F. Barlow currently holds 15,000 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James F. Barlow has been a net seller of ARCT stock. They have purchased $0 and sold $13.1M worth of shares.
James F. Barlow's most recent insider trade was on Jun 14, 2024, when they sold 3,131 shares at $0.00 per share.
James F. Barlow serves as Executive at Arcturus Therapeutics Holdings Inc. (ARCT). They have executed 79 insider transactions totaling $13.1M over their tenure at the company.
James F. Barlow holds the position of Executive at Arcturus Therapeutics Holdings Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James F. Barlow has shown a selling trading pattern, with $0 in total purchases and $13.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James F. Barlow was on Sep 15, 2010, when they sold $2.4M worth of AGN shares. This transaction involved 35,721 shares at $66.12 per share.
James F. Barlow currently owns 15,000 shares of Arcturus Therapeutics Holdings Inc. (ARCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James F. Barlow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James F. Barlow has 79 Form 4 filings on record as an insider at Arcturus Therapeutics Holdings Inc..
Set alerts for James F. Barlow and 40,000+ other insiders.